The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are investigating a multistate outbreak of fungal meningitis among patients who received an epidural injection containing steroid medication made by the New England Compounding Center (NECC), a Massachusetts compounding pharmacy. To date 105 people in 9 states are confirmed as part of the outbreak.
The case count of the meningitis outbreak by state is as follows, according to the CDC: Florida (4), Indiana (11), Maryland (5 and 1 death), Michigan (21 and 2 deaths), Minnesota (3), North Carolina (2), Ohio (1), Tennessee (35 with 4 deaths), and Virginia (23 with 1 death). Many of these people had strokes associated with the meningitis. Investigators have found fungus, Aspergillus and Exserohilum, in cultures of the cerebrospinal fluid of some of the outbreak victims. Most of the cases in Tennessee were caused by Exserohilum.
Attorney Fred Pritzker, who has been contacted by victims of this epidural meningitis outbreak, is gathering evidence for a lawsuit against the New England Compounding Center. “Victims of this outbreak and their families need answers,” said Pritzker, who recently won over $40,000,000 for clients injured by another medical product. “Good safety practices should prevent this kind of fungal contamination and adequate testing should prevent any contaminated product from injuring and killing patients. Something went terribly wrong here.” Pritzker is available for a free consultation.
The states that received the implicated NECC steroid include California, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Maryland, Michigan, Minnesota, North Carolina, New Hampshire, New Jersey, Nevada, New York, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Virginia, Texas, and West Virginia.